Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Energy Focus Inc.

Start price
Target price
Perf. (%)
€0.93
29.09.24
-
29.09.25
11.83%
03.10.24

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.84
28.09.24
-
28.09.25
-
28.09.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
28.09.24
-
28.09.25
-
07.01.23

Arca Biopharma

Start price
Target price
Perf. (%)
€2.22
28.09.24
-
28.09.25
-
30.08.24

Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.22
28.09.24
-
28.09.25
-
15.12.23

buy
GAIL India Ltd. ADR

Start price
Target price
Perf. (%)
€15.70
28.09.24
€15.00
28.09.25
-3.18%
03.10.24

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€25.72
28.09.24
€12.00
28.09.25
-4.12%
04.10.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Aytu Biopharma Inc.

Start price
Target price
Perf. (%)
€2.06
28.09.24
€1.00
28.09.25
2.91%
03.10.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.22
28.09.24
€25.00
28.09.25
5.68%
04.10.24

buy
Plus Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.83
28.09.24
€2.00
28.09.25
-35.38%
03.10.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.22
28.09.24
€12.00
28.09.25
5.68%
04.10.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
buy
IperionX Ltd.

Start price
Target price
Perf. (%)
€1.91
27.09.24
-
27.09.25
10.97%
04.10.24

Ceres Power Holdings

Start price
Target price
Perf. (%)
€2.96
27.09.24
-
27.09.25
1.56%
28.09.24

buy
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€25.36
27.09.24
-
27.10.24
-2.76%
04.10.24

Englobal

Start price
Target price
Perf. (%)
€0.22
27.09.24
-
27.09.25
-
30.11.23

Innodata Inc.

Start price
Target price
Perf. (%)
€14.05
27.09.24
-
27.09.25
1.07%
04.10.24

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€28.40
27.09.24
-
27.09.25
-1.41%
03.10.24

buy
Donnelley Financial Solutions Inc

Start price
Target price
Perf. (%)
€58.00
27.09.24
€70.54
27.09.25
1.72%
03.10.24

buy
State Bank of India GDR

Start price
Target price
Perf. (%)
€85.00
27.09.24
€88.00
27.09.25
3.53%
04.10.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Atco Ltd NV

Start price
Target price
Perf. (%)
€32.20
26.09.24
€33.00
26.09.25
1.24%
04.10.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very high dividend yield expected
Good rating
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.75
26.09.24
-
26.09.25
14.29%
04.10.24

Recon Technology Ltd.

Start price
Target price
Perf. (%)
€0.088
26.09.24
-
26.09.25
-
30.04.24

Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.41
26.09.24
-
26.09.25
-
21.03.24

buy
Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€21.80
26.09.24
-
26.09.25
-
24.02.22

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
26.09.24
€71.72
26.09.25
-6.04%
03.10.24